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Abstract 
The convenient and straightforward preparation of dideoxy-1,4- and 1,5-iminopentitol 
derivatives from protected sugar hemiacetals by way of N-tert-butanesulfinyl glycosylamines 
and open-chain aminoalditols is reported. The synthetic procedure is a method of choice for 
the making of these important scaffolds of biological interest. 
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1. Introduction 
Polyhydroxylated pyrrolidines and piperidines known as 1,4- and 1,5-dideoxyiminosugars 
have been known as natural products since the discovery of fagomine (1,2-dideoxynojirimycin, 
Figure 1) and moranoline in the 1970’s [1,2]. The name ‘moranoline’ was later abandoned and 
1-deoxynojirimycin (DNJ) preferred. A large diversity of 1-deoxyiminosugars was found a 
posteriori in microorganisms and plants [e.g., DMDP (2,5-dihydroxymethyl-3,4-
dihydroxypyrrolidine also known as 2,5-dideoxy-2,5-imino-D-mannitol), Figure 1] [3] and 
many new structures synthesized [4]. The biological studies on these compounds revealed their 
remarkable properties as inhibitors of glycosidases, as well as of other carbohydrate-processing 
enzymes [5]. When protonated, they mimic charge and shape of the cationic intermediates 
generated in the glycosidase catalyzed reactions. As such, these sugar analogues have 
considerable therapeutic potential and three 1-deoxy-1,5-iminohexitol derivatives have now 
been commercialized as drugs (Figure 1) [6]. 
 
Figure 1. Natural 1-deoxyiminosugars and derivatives used as drugs. 
A diversity of synthetic methodologies have been developed to access 1-deoxyiminosugars 
in the piperidine and pyrrolidine series, most often from sugars as starting materials [7]. Such 
methods include for example, from protected, reducing aldo-furanoses or –pyranoses, double 
oxidation-double reductive amination sequences [8] or reduction, double mesylation and 
double SN2 reactions [9]. Also from aldonolactones, formation of an open-chain amide, 
cyclization by oxidation and reductive amination to generate a lactam and reduction of the 
carbonyl group [10] has proven to be a convenient method. Remarkably, all these synthetic 
routes appear to be methods of choice although manipulation of the oxo-intermediates is 
commonly quite challenging and double reductive amination protocols give typically moderate 
overall yields (~ 50%) over long reaction times (48 h). Of relevance to our work is the method 
of Buchanan and Wrightman who reported the synthesis of a 2,3,5-tri-O-benzyliminoxylitol by 
a three-step procedure via an open chain oxime [11]. The technique consisting in forming a 
glycosylamine and reacting it with a nucleophile to generate an open-chain aminoalditol has 
been used mostly with C-nucleophiles to reach eventually 1-C-susbtituted iminoalditol 
compounds in the pyrrolidine and piperidine series [12]. The in situ or stepwise reductive 
amination of sugar hemiacetals with amines by way of a glycosylamine, followed by the 
activation of the free OH group and cyclisation was reported by a few authors [13,14] as an 
approach to 1-deoxyiminosugars but remained limited to few examples and their generality 
was not demonstrated. Furthermore, the reaction sequences involved generally long periods of 
time (usually ≥ 16 h) and/or low temperatures, the iminosugar compounds being obtained in 
their N-protected form; thus requiring an additional step for deprotection. 
As shown in our previous work, N-tert-butanesulfinyl glycosylamines are highly efficient 
aldose imine surrogates and their reactions with organometallic nucleophiles have led to a 
diversity of 1-C-substituted iminoalditols derivatives [15]. On this basis, a short, general and 
convenient synthetic route to 1-deoxyiminoalditols using hydride as the nucleophile was 
envisaged (Figure 2). 
 
Figure 2. Synthetic plan from protected Hemiacetals. 
Combined with the cyclisation of the resulting open-chain aminoalditols, the route should lead 
in very few steps and short reaction times to protected or deprotected cyclic iminopentitols. 
We report in this note the implementation of the methodology. 
2. Results and Discussion  
Starting from known tri-O-benzyl pentofuranoses (1a, 1b), formation of the sulfinyl 
glycosylamines of type 2 was executed under conditions improved from the ones we previously 
described [15]. Thus, using Ti(OEt)4 as the promoter and (R)-(+)-2-methyl-2-
propanesulfinamide ((R)-3, 2 equiv.) in dry toluene, compounds (SR)-2a (83%) and (SR)-2b 
(86%) could be isolated in excellent yields after 1.5 h at 110 °C. Addition of NaBH4 (4 equiv.) 
was then performed in toluene at room temperature (ca. 20 °C) with the D-
arabinofuranosylamine (SR)-2b to obtain compound (SR)-4b in good yield (84%, 72% over 2 
steps) after a reaction time of 20 h. Alternatively, for the synthetic utility of the proposed study, 
the glycosylamines were not isolated. Instead, step (1) was carried out, and the crude reaction 
mixture was directly treated with NaBH4 (4 equiv.) at 110 °C for 1 h to afford the corresponding 
iminoalditols ((SR)-4a and (SR)-4b) in high yields (e.g., 76 and 74% respectively over the two-
step sequence G.P. A). 
Of note, the reaction sequence could also be realized using the (S)-(‒)-chiral sulfinyl 
auxiliary. Heating under microwave irradiation (i.e., 110 °C for 1.5 h) could also be achieved 
in step (1) to form the sulfinyl glycosylamines in comparable yields with that under standard 
heating. Subsequent reduction at 110 °C for 1 h could then be carried out at the bench, with no 
improvement of the reaction sequence yield (Scheme 1). Notably, synthesis of the aminoalditol 
compounds 4 could not be fully accomplished under microwave irradiation as a dramatic yield 
decrease was observed for the reduction step (e.g., 58% for (SR)-4b). The free OH position was 
next activated as a mesylate, and the crude mesylate treated with t-BuOK (0 °C or 20 °C, 0.5-
1.5 h) to perform the cyclization, thus giving pyrrolidine derivatives (SR)-5a and (SR)-5b in 
moderate yields (66‒69%). 
 
Scheme 1. Reactions of pentofuranose hemiacetals. G.P. A: step (1), then addition of NaBH4 (4 eq.), 
110 °C, 1 h (compound 2 not isolated); G.P. B: step (3) and (5) (use of crude 5). 
The sulfinyl group was cleaved by simple treatment with acidic methanol to give 6a and 6b 
in good yield (93%) [15a]. Once again, the two reactions could be completed in a single 
sequence. The sulfinyl group could be cleaved from the intermediate mesylate, which was not 
isolated and subsequently cyclized upon acidification and neutralisation of the reaction mixture 
with a basic anion exchange resin (step (3) and (5), G.P. B), thus giving directly 6a and 6b 
from (SR)-4a and (SR)-4b in 72 and 70% yield respectively [15b]. Starting from L-xylofuranose 
derivative 1a [16], the sequence gave the O-benzylated 1,4-imino-D-arabinitol 6a, and from D-
arabinofuranose 1b [17], the corresponding 1,4-imino-L-xylitol derivative 6b was obtained, 
both resulting from an inversion of configuration at C-4 upon ring closure. Compound 6a was 
then deprotected by hydrogenolysis to afford the known D-DAB 7a as its hydrochloride salt 
[10a]. 
The scope of the reactions was then extended and the same sequence was applied to a tri-
O-benzylated pentopyranose, with the goal of forming a 1,5-dideoxy-1,5-iminopentitol 
derivative. 3,4,5-Trihydroxypiperidines and their N- and O-alkylated and arylated synthetic 
derivatives have been shown exhibiting outstanding array of biological activities and promising 
potential in the area of antibacterial, anti-inflammatory and antiviral agents [18]. 
 
Scheme 2. Reaction of a L-lyxopyranose hemiacetal. P. C: Step (1), then evaporation of the solvent 
and step (2) carried out. 
The known tri-O-benzyl-L-lyxopyranose 8 [19] was thus prepared in three steps from L-
lyxose. Reaction with Ellman's (R)-tert-butanesulfinamide was performed at 110 °C to give the 
desired glycosylamine (SR)-9 readily (Scheme 2). The L-lyxopyranosylamine derivative was 
not soluble in toluene. It could be isolated (77%) and characterized. Importantly, heating under 
W irradiation was mandatory to allow formation of (SR)-9 in good yield over a short period 
of time [20]. Afterwards, the toluene was evaporated and the crude compound (SR)-9 was 
reduced to the corresponding aminopentitol derivative (SR)-10 (64%) upon addition of NaBH4 
(4 equiv.) in EtOH at 80 °C for 2 h (49% over two steps). Step (1) and (2) could obviously be 
performed without isolation of (SR)-9 to give (SR)-10 in good overall yield (56%, P. C). The 
open-chain compound was thereafter cyclized by way of the mesylate under the conditions 
described for the pyrrolidines (G.P. B), thus affording the 1,5-dideoxy-1,5-imino-L-lyxitol 11 
in moderate yield (44%). 
3. Conclusion 
We have reported in this note a brief synthesis of protected or free 1,4-imino or 1,5-
iminopentitol derivatives using a sulfinyl glycosylamine as an aldose imine equivalent. 
Reduction of the latent imine provides an open-chain aminoalditol, which can be readily 
cyclized by an internal SN2 process. This method will be applicable to a large diversity of sugar 
hemiacetals to prepare the corresponding cyclic iminoalditols in good overall yields in a 
convenient and straightforward manner. Noteworthy, although the use of a chiral sulfinyl group 
is required for the proposed study, the sulfinylamino function has optimal properties to allow 
implementation of this methodology: stable glycosylamine and open-chain intermediates, 
favourable reactivity of the latent N-sulfinyl imine, and ready deprotection of the nitrogen 
atom, thus providing the possibility of post-functionalisation of this endocyclic atom. 
4. Experimental section 
4.1. General remarks 
Unless otherwise stated, all reagents were purchased from commercial suppliers and used 
as received. Toluene (puriss. p.a., ACS reagent, ≥ 99.7% (GC)) and THF (99.9% GC) with 2,6-
di-tert-butyl-4-methylphenol (250 mg/L) as stabilizer were purified by passage through a 
column containing activated alumina under nitrogen pressure (Dry Solvent Station GT S100, 
GlassTechnology, Geneva, CH). Dichloromethane (99.99% GC) was distilled from calcium 
hydride (CaH2) and used as solvent in reactions under anhydrous conditions. Methanol 
(anhydrous, 99.8%) and N,N-dimethylformamide (anhydrous, 99.8%) were purchased from 
Sigma-Aldrich. MS 4 Å was activated by drying in an oven at 500 °C (48 h). It was then 
allowed to reach room temperature (ca. 20 °C) and kept over CaCl2 in a desiccator prior to use. 
Amberlite® IRA-400 was prepared in its OH‾ form by passing 1M KOH until the effluent is 
free from chloride ions, then washed with distilled H2O until neutral and MeOH. Microwave 
activation was performed in sealed vessel, using a Biotage Initiator system. The following 
setting was used: Normal absorption level, Fixed Hold Time: on, Power: 100 Watt, Hold time: 
90 minutes, Temperature: 110 °C. The internal temperature was measured by an IR-sensor. 
NMR spectra were recorded at 298 K with a Bruker Avance III HD nanobay 400 MHz 
spectrometer equipped with a BBO probe. The structures of the new compounds were assigned 
with the aid of 1 D [1H NMR, 13C NMR, Distortionless Enhancement by Polarization Transfer 
(DEPT)] and 2 D Correlation Spectroscopy [(1H−1H COSY and 1H−13C Heteronuclear Single 
Quantum Coherence (HSQC)] experiments. 1H NMR (400 MHz) chemical shift values are 
listed in parts per million (ppm). Tetramethylsilane (TMS) was used as an internal standard, or 
alternatively, spectra were calibrated using the signals of the corresponding non-deuterated 
solvent. Data are reported as follows: chemical shift (ppm on the  scale), multiplicity (s = 
singlet, d = doublet, t = triplet, q = quartet and m = multiplet), coupling constant Ј (Hz), and 
integration. 13C NMR (101 MHz) chemical shifts are given in ppm. Spectra were calibrated 
using the corresponding non-deuterated solvent or TMS as an internal standard. NMR primary 
data should be processed by MestReNova. High-resolution mass spectra were recorded with a 
Brucker maXis ESI qTOF ultrahigh-resolution mass spectrometer coupled to a Dionex 
Ultimate 3000 RSLC system (FR2708, Orléans). MS data were acquired in positive mode and 
were processed using Data Analysis 4.4 software (Bruker). Infrared spectra were recorded with 
a Thermo Scientific Nicolet IS10 FTIR spectrometer using diamond ATR golden gate sampling 
and are reported in wave numbers (cm–1). Specific optical rotations were measured with a 
JASCO P-2000 digital polarimeter, in a thermostated (20 °C) 1 dm long cell with high-pressure 
sodium lamp and are reported as follow: [α]DT [solvent, c (g/100 mL)]. Analytical thin-layer 
chromatography (TLC) was performed with Merck Silica Gel 60 F254 precoated plates. 
Visualization of the developed chromatogram was performed under ultraviolet light (254 nm) 
and on staining by immersion in aqueous, acidic ceric ammonium molybdate followed by 
charring at 150 °C. Flash chromatography was performed in air on Silica Gel 60 (230–400 
mesh) with petroleum ether (PE, bp 40–65 °C) and ethyl acetate as eluents, unless otherwise 
stated. Organic solutions were concentrated under reduced pressure with a Buchi rotary 
evaporator. 
 
4.2. General procedures 
4.2.1. General procedure for the preparation of 1-N-tert-butanesulfinylamino-1-deoxy-pentitol 
derivatives of type 4a and 4b from protected sugar hemiacetals (1a, 1b) (G.P. A).  
A single-necked flask equipped with a reflux condenser and an argon inlet system was 
charged with related tri-O-benzyl-pentofuranose, 4 Å activated molecular sieves (0.4 g per 
mmol of substrate) and (S)- or (R)-2-methyl-2-propanesulfinamide (2.0 equiv.). Dry toluene (4 
mL per mmol of substrate) was inserted and the mixture was stirred for 5 min at room 
temperature (~20 °C). Titanium(IV) ethoxide (Ti(OEt)4, 1.5 equiv.) was then added and the 
reaction mixture was stirred at 110 °C until no more starting material was observed by TLC 
(generally, 1.5 h). The content was next allowed to reach 20 °C and NaBH4 (4.0 equiv.) was 
added. The resulting suspension was stirred at 110 oC until no more sulfinyl glycosylamine 
intermediate remained in the reaction mixture (1 h). The suspension was then allowed to cool 
down to room temperature and sat. aqueous NaCl was added. The mixture was stirred at 20 °C 
for 10 min and the precipitate and molecular sieves were filtered through a pad of celite®. The 
cake was rinsed (EtOAc) and the aqueous layer was discarded. The organic phase was washed 
(sat. aq. NH4Cl), dried over MgSO4, filtered through a cotton plug and concentrated in vacuo. 
The crude product was purified through column chromatography (SiO2, PE:EtOAc) to provide 
the 1-N-tert-butanesulfinylamino-1-deoxy-pentitol derivative. 
4.2.2. General procedure for the Synthesis of 1,4-Dideoxy-1,4-iminopentitol derivatives of type 
6a and 6b and 1,5-Dideoxy-1,5-imino-L-lyxitol 11, from corresponding N-tert-
butanesulfinylamino-1-deoxy-pentitols (G.P. B). 
To a solution of compound 4 in anhydrous CH2Cl2 (0.08 M), under argon atmosphere, were 
added Et3N (2.2 equiv.) and MsCl (2.0 equiv.) and the reaction mixture was stirred at room 
temperature until no more starting material was present (30−60 min). The mixture was then 
diluted (CH2Cl2) and the organic phase was washed with aq. NH4Cl. The aqueous phase was 
extracted 3× with CH2Cl2 and the combined organic phases were dried over MgSO4. The 
solvent was evaporated at the evaporator to give the crude mesylated intermediate which was 
used in the next cyclization step without further purification. 
A single-necked flask under argon atmosphere was charged with AcCl (5 equiv., 0.4 M) and 
dry MeOH and the mixture was stirred at 20 °C for 30 min (solution A). Another flask under 
argon atmosphere (flask B) was charged with dry MeOH and crude mesylated intermediate 
(0.4 M), and solution A was added through syringe to flask B. The reaction mixture was stirred 
for 1 h; Amberlite IRA-400 (OH– form) ion-exchange resin was then added until pH 8. The 
mixture was stirred further for 1 h at the same temperature and the suspension was filtered 
through a cotton plug. The solvents were evaporated under reduced pressure and the residue 
was purified by chromatography to provide compound 6a, 6b or 11 in good yield. 
4.3. Synthesis of Compounds 4-7 and 9-11. 
4.3.1. 2,3,5-Tri-O-benzyl-1-[(SR)-N-tert-butanesulfinylamino]-1-deoxy-L-xylitol (SR)-4a. 
Compound (SR)-4a was synthesized according to G.P. A, and isolated as a colorless oil (1.9 
g, 76%). Rf 0.2 (SiO2, PE:EtOAc 1:1) 
1H NMR (400 MHz, CDCl3/TMS): δ 7.36–7.21 (m, 15 
H, HAr), 4.78–4.38 (m, 6 H, OCH2Ph), 4.00–3.87 (m, 2 H, H-4, H-2), 3.70 (dd, J = 6.1, 2.2 Hz, 
1 H, H-3), 3.60–3.43 (m, 3 H, H-1a, H-5a, NH), 3.39 (dd, J = 9.3, 6.4 Hz, 1 H, H-5b), 3.27 (dt, 
J = 12.7, 6.2 Hz, 1 H, H-1b), 2.48 (d, J = 7.5 Hz, 1 H, OH), 1.16 (s, 9 H, tBu) ppm. 13C NMR 
(101 MHz, CDCl3/TMS): δ 138.0 (C, CAr), 138.0 (C, CAr), 137.9 (C, CAr), 128.5–127.7 (CH, 
CHAr), 79.3 (CH, C-2), 77.3 (CH, C-3), 74.3 (CH2, OCH2Ph), 73.3 (CH2, OCH2Ph), 72.8 (CH2, 
OCH2Ph), 71.3 (CH2, C-5), 68.9 (CH, C-4), 55.8 (C, tBu), 45.7 (CH2, C-1), 22.6 (CH3, tBu) 
ppm. HRMS (ESI): calcd. for C30H40NO5S [M+H
+] 526.2627; found 526.2621. 
4.3.2. 2,3,5-tri-O-benzyl-(SR)-N-tert-butanesulfinyl-1,4-dideoxy-1,4-imino-D-arabinitol (SR)-
5a. 
To a solution of compound (SR)-4a (200 mg, 0.38 mmol) in anhydrous CH2Cl2 (5 mL), 
under argon atmosphere were added triethylamine (113 µL, 0.84 mmol) and MsCl (59 µL, 0.76 
mmol) and the reaction mixture was stirred at room temperature for 1 h. The mixture was 
diluted by addition of CH2Cl2 (20 mL) and the organic solution was washed with saturated aq. 
NaCl (30 mL). Next, the aqueous phase was extracted with CH2Cl2 (2 × 20 mL) and combined 
organic phases were dried over MgSO4 and filtered over a cotton plug. Solvent removal through 
rotary evaporation gave the crude mesylated intermediate which was used for the cyclisation 
step without further purification. 
To a solution of the just generated mesylated intermediate in anhydrous THF (5 mL) under 
argon atmosphere was added t-BuOK (85 mg, 0.76 mmol) and the reaction mixture was stirred 
at 20 °C for 30 min. Saturated aq. NH4Cl (10 mL) was then added and the mixture was extracted 
with EtOAc (3 × 15 mL). Next, the combined organic phases were washed with saturated aq. 
NaCl (20 mL), dried over MgSO4, filtered over a cotton plug and concentrated under vacuum. 
The crude product was purified by flash chromatography (SiO2, PE : EtOAc 2:1) to give (SR)-
5a (132 mg, 69%) as colorless oil. Rf 0.32 (SiO2, PE:EtOAc 2:1). [α]D20 −9.6 (c 1.0, CHCl3); 
1H NMR (400 MHz, CDCl3/TMS): δ 7.37–7.20 (m, 15 H, HAr), 4.60 (s, 2 H, OCH2Ph), 4.51–
4.40 (m, 4 H, OCH2Ph), 4.08–3.97 (m, 3 H, H-1a, H-2, H-3), 3.86–3.77 (m, 1 H, H-4), 3.57–
3.46 (m, 2 H, H-5), 2.79 (dd, J = 10.2, 4.3 Hz, 1 H, H-1b), 1.15 (s, 9 H, tBu) ppm. 13C NMR 
(101 MHz, CDCl3/TMS): δ 138.2 (C, CAr), 138.1 (C, CAr), 137.9 (C, CAr), 128.5−127.6 (CH, 
CHAr), 83.1 (CH, C-2 or C-3), 82.1 (CH, C-3 or C-2), 73.1 (CH2, OCH2Ph), 72.1 (CH2, 
OCH2Ph), 71.6 (CH2, OCH2Ph), 71.2 (CH2, C-5), 68.26 (CH, C-4), 57.6 (C, tBu), 44.8 (CH2, 
C-1), 23.6 (CH3, tBu) ppm. IR (neat): 3021 (C−H), 2929 (C−H), 2857 (C−H), 1714, 1451 
(C=C), 1064 (C−O), 739 (C−H), 694 (C−H) cm–1. HRMS (ESI): calcd. for C30H38NO4S 
[M+H+] 508.2522; found: 508.2519. 
4.3.3. 2,3,5-Tri-O-benzyl-1,4-dideoxy-1,4-imino-D-arabinitol 6a. 
Compound 6a was synthesized from imino-L-xylitol (SR)-4a according to G.P. B. It was 
isolated as a colorless oil (110 mg, 72%). Rf 0.45 (SiO2, CH2Cl2:MeOH 15:1). NMR data are 
consistent with that of the literature [10a]. [α]D20 −1.0 (c 1.0, CHCl3); 1H NMR (400 MHz, 
CDCl3/TMS): δ 7.31–7.21 (m, 15 H, HAr), 4.59–4.39 (m, 6 H, OCH2Ph), 4.05–3.97 (m, 1 H, 
H-2), 3.87 (dd, J = 4.8, 1.9 Hz, 1 H, H-3), 3.61 (dd, J = 9.5, 5.1 Hz, 1 H, H-5a), 3.55 (dd, J = 
9.5, 5.6 Hz, 1 H, H-5b), 3.24 (q, J = 4.8 Hz, 1 H, H-4), 3.09 (d, J = 3.6 Hz, 2 H, H-1), 2.24 (br 
s, 1 H, NH) ppm. 13C NMR (101 MHz, CDCl3/TMS): δ 138.3 (C, CAr), 138.2 (C, CAr), 138.2 
(C, CAr), 128.4–127.6 (CH, CHAr), 85.8 (CH, C-3), 84.6 (CH, C-2), 73.2 (CH2, OCH2Ph), 71.9 
(CH2, OCH2Ph), 71.1 (CH2, OCH2Ph), 70.4 (CH2, C-5), 64.2 (CH, C-4), 51.1 (CH2, C-1) ppm. 
IR (neat): 3034 (C−H), 2917 (C−H), 2863 (C−H), 1739, 1451 (C=C), 1087 (C−O), 736 (C−H), 
688 (C−H) cm–1. HRMS (ESI): calcd. for C26H30NO3 [M+H+] 404.2226; found: 404.2218. 
Alternatively, it could be prepared by removal of the chiral sulfinyl auxiliary from imino-
D-arabinitol 5a. 
In a 2-mL single-necked round-bottomed flask under argon atmosphere was inserted AcCl 
(17 μL, 0.24 mmol) and dry MeOH (0.5 mL) and the solution was stirred at 20 °C for 30 min 
(solution A). In parallel, another 2-mL flask under argon atmosphere was charged with imino-
D-arabinitol (SR)-5a (30 mg, 0.06 mmol) and solution A was added through syringe. The 
reaction mixture was stirred for 15 min and neutralized by addition of resin Amberlite IRA-
400 (OH– form) until pH 8. The solution was filtered through a cotton plug and concentrated 
under vacuum to afford 6a in good yield (23 mg, 93%). 
4.3.4. 1,4-Dideoxy-1,4-imino-D-arabinitol 7a.HCl. 
A vigorously stirred suspension of 6a (70 mg, 0.173 mmol), 20% Pd(OH)2−C (40 mg), and 
aq. HCl (1 N, 0.6 mmol, 600 μL) in iPrOH (5 mL) was degassed under vacuum and saturated 
with hydrogen (3x). The reaction mixture was stirred at 20 °C for 48 h under hydrogen 
atmosphere (balloon of H2). The mixture was filtered over a pad of celite® and the solid residue 
was rinsed with MeOH. The solvents were evaporated under reduced pressure to give 7a.HCl 
as colorless syrup in quantitative yield (29 mg). Characterization data are consistent with those 
reported in the literature [10a]. 1H NMR (400 MHz, D2O): δ 4.37–4.31 (m, 1 H, H-2), 4.15–
4.06 (m, 1 H, H-3), 3.96 (dd, J = 12.2, 4.6 Hz, 1 H, H-5), 3.84 (dd, J = 12.2, 8.2 Hz, 1 H, H-5), 
3.67–3.54 (m, 2 H, H-4, H-1a), 3.37 (d, J = 12.6 Hz, 1 H, H-1b) ppm. 13C NMR (101 MHz, 
D2O): δ 75.6 (CH, C-3), 74.2 (CH, C-2), 66.6 (CH, C-4), 58.9 (CH2, C-5), 50.0 (CH2, C-1) 
ppm. HRMS (ESI): calcd. for C5H12NO3 [M+H
+] 134.0817; found: 134.0812. 
4.3.5. 2,3,5-Tri-O-benzyl-1-[(SR)-N-tert-butanesulfinylamino]-1-deoxy-D-arabinitol (SR)-4b. 
The title compound was synthesized according to G.P. A to afford (SR)-4b as yellowish 
syrup (277 mg, 74%). Rf 0.1 (SiO2, PE:EtOAc 5:5). [α]D20 –34.5 (c 0.78, CHCl3). 1H NMR 
(400 MHz, CDCl3/TMS): δ 7.39–7.22 (m, 15H, HAr), 4.70–4.48 (m, 6 H, 3 × OCH2Ph), 4.02–
3.94 (br m, 1 H, H-4), 3.92–3.86 (m, 1 H, H-2), 3.71–3.59 (m, 3 H, H-3, H-5a, H-5b), 3.46–
3.25 (m, 3 H, H-1a, H-1b, NH), 2.92 (br s, 1 H, OH), 1.13 (s, 9 H, tBu) ppm. 13C NMR (101 
MHz, CDCl3/TMS): δ 138.1 (C, CAr), 138.0 (C, CAr), 137.8 (C, CAr), 128.7–127.9 (CH, CHAr), 
79.4 (CH, C-2), 77.4 (CH, C-3), 73.7 (CH2, OCH2Ph), 73.6 (CH2, OCH2Ph), 73.3 (CH2, 
OCH2Ph), 71.2 (CH2, C-5), 70.7 (CH, C-4), 55.9 (C, tBu), 45.6 (CH2, C-1), 22.7 (CH3, tBu) 
ppm. IR (neat): 3309 (O−H), 3062 (C−H), 3030 (C−H), 2865 (C−H), 1454 (C=C), 1068 (C−O), 
735 (C−H), 697 (C−H) cm–1. HRMS (ESI): calcd. for C30H40NO5S [M+H+] 526.2622; found 
526.2622. 
Alternatively, it could be prepared by reduction of the isolated glycosylamine derived from 
1b, compound 2b [15b]. 
An oven-dried 5-mL single-necked round-bottomed flask was charged with compound (SR)-
2b (50 mg, 95 mol) and flushed with argon. Dry THF (0.5 mL) was inserted (syringe) and 
NaBH4 (7 mg, 0.19 mol) was added in one portion. The reaction mixture was then allowed to 
stir at 20 °C for 20 h under argon atmosphere. The mixture was quenched by the addition of 
aq. NH4Cl (10 mL), and it was extracted twice with EtOAc (2 × 10 mL). The combined organic 
phases were dried (Na2SO4), filtered through a cotton plug and the solvents were evaporated 
under reduced pressure. The crude product was purified by column chromatography (SiO2, 
PE:EtOAc 5:5 to 3:7) to afford D-arabinitol (SR)-4b in good yield (42 mg, 84%). 
4.3.6. 2,3,5-Tri-O-benzyl-(SR)-N-tert-butanesulfinyl-1,4-dideoxy-1,4-imino-L-xylitol (SR)-5b. 
To a solution of compound (SR)-4b (96 mg, 0.18 mmol) in anhydrous CH2Cl2 (3.5 mL), in 
the presence of 4Å MS, under argon atmosphere were added Et3N (100 µL, 0.73 mmol) and 
MsCl (57 µL, 0.73 mmol) and the reaction mixture was stirred at 20 °C for 30 min. The 
molecular sieves were filtered through Celite®, the cake rinsed with CH2Cl2 and the organic 
solution washed with aq. NH4Cl (10 mL). Next, the aqueous phase was extracted once with 
CH2Cl2, combined organic phases were dried over MgSO4 and filtered over a cotton plug. 
Solvent evaporation gave the crude mesylated intermediate which was used in the cyclisation 
step without further purification. 
To a solution of the just generated mesylated intermediate in anhydrous THF (3.5 mL) under 
argon atmosphere was added t-BuOK (40 mg, 0.36 mmol) and the reaction mixture was stirred 
at 0 °C for 1 h. Extra t-BuOK (20 mg, 0.18 mmol) was added and stirring was pursued for 
another 30 min. Aqueous NH4Cl (10 mL) was then added and the mixture was extracted twice 
with EtOAc (2 × 5 mL). The combined organic phases were then washed with saturated aq. 
NaCl, dried over MgSO4, filtered over a cotton plug and concentrated under vacuum. The crude 
product was purified by flash chromatography (SiO2, PE:EtOAc 7:3) to give (SR)-5b (60 mg, 
66%) as a pale yellow oil. 
Rf 0.4 (SiO2, PE:EtOAc 7:3). [α]D20 –36.1 (c 1.06, CHCl3). 1H NMR (400 MHz, 
CDCl3/TMS): δ 7.40–7.19 (m, 15 H, HAr), 4.64–4.42 (m, 6 H, OCH2Ph), 4.17 (dt, J = 6.9, 4.3 
Hz, 1 H, H-2), 4.06 (dd, J = 6.0, 4.6 Hz, 1 H, H-3), 4.01–3.94 (m, 1 H, H-4), 3.87 (dd, J = 11.5, 
6.9 Hz, 1 H, H-1a), 3.74 (d, J = 4.8 Hz, 2 H, H-5), 3.02 (dd, J = 11.5, 3.7 Hz, 1 H, H-1b), 1.16 
(s, 9 H, tBu) ppm. 13C NMR (101 MHz, CDCl3/TMS): δ 138.3 (C, CAr), 138.1 (C, CAr), 138.1 
(C, CAr), 128.4−127.5 (CH, CHAr), 83.2 (CH, C-3), 81.5 (CH, C-2), 73.5 (CH2, OCH2Ph), 72.5 
(CH2, OCH2Ph), 71.8 (CH2, OCH2Ph), 68.2 (CH2, C-5), 59.7 (CH, C-4), 57.7 (C, tBu), 51.2 
(CH2, C-1), 23.1 (CH3, tBu) ppm. IR (neat): ν = 3029 (C−H), 2924 (C−H), 2865 (C−H), 1454 
(C=C), 1362, 1074 (C−O), 1028 (C−N), 753 (C−H) cm-1. HRMS (ESI): calcd. for C30H38NO4S 
[M+H+] 508.2516; found: 508.2515. 
4.3.7. 2,3,5-Tri-O-benzyl-1,4-dideoxy-1,4-imino-L-xylitol 6b. 
The titled compound was synthesized from (SR)-4b according to G.P. B to afford 6b as a 
yellow oil (51 mg, 70 %). Rf 0.4 (SiO2, CH2Cl2:MeOH 9:1). [α]D20 +7.9 (c 0.96, CHCl3). 1H 
NMR (400 MHz, CDCl3/TMS): δ 7.39–7.20 (m, 15 H, HAr), 4.60–4.42 (m, 6 H, 3 × OCH2Ph), 
4.05–3.93 (m, 2 H, H-2, H-3), 3.73–3.69 (m, 1 H, H-5a), 3.66–3.58 (m, 1 H, H-5b), 3.49 (dd, 
J = 11.5, 5.5 Hz, 1 H, H-4), 3.35 (dd, J = 11.8, 5.6 Hz, 1 H, H-1a), 2.90 (d, J = 12.0 Hz, 1 H, 
H-1b), 2.25 (br s, 1 H, NH) ppm. 13C NMR (101 MHz, CDCl3/TMS): δ 138.5 (C, CAr), 138.3 
(C, CAr), 138.2 (C, CAr), 128.5−127.7 (CH, CHAr), 83.2 (CH, C-2 or C-3), 82.9 (CH, C-3 or C-
2), 73.5 (CH2, OCH2Ph), 71.9 (CH2, OCH2Ph), 71.5 (CH2, OCH2Ph), 69.3 (CH2, C-5), 60.5 
(CH, C-4), 50.9 (CH2, C-1) ppm. IR (neat): 3062 (C−H), 3029 (C−H), 2914 (C−H), 2861 
(C−H), 1453 (C=C), 1094 (C−O), 1027 (C−N), 735 (C−H), 697 (C−H) cm−1. HRMS (ESI): 
calcd. for C26H30NO3 [M+H
+] 404.2220; found: 404.2220. 
Alternatively, compound 6b could be obtained from imino-L-xylitol 5b. 
In a 10-mL single-necked round-bottomed flask under argon atmosphere was inserted AcCl 
(37 μL, 0.52 mmol) and dry MeOH (3.0 mL) and the solution was stirred at 20 °C for 30 min 
(solution A). In parallel, another 10-mL flask under argon atmosphere was charged with imino-
L-xylitol (SR)-5b (53 mg, 0.104 mmol) and solution A was added through syringe. The reaction 
mixture was stirred for 15 min and neutralized by addition of resin Amberlite IRA-400 (OH– 
form) until pH 8. The solution was filtered through a cotton plug and concentrated under 
vacuum to afford 6b in good yield (39 mg, 93%). 
4.3.8. 2,3,4-tri-O-benzyl-(SR)-N-tert-butanesulfinyl-α/β-L-lyxopyranosylamine (SR)-9. 
A 5-mL microwave vial under argon atmosphere was charged with 2,3,4-tri-O-benzyl-L-
lyxopyranose (0.5 g, 1.19 mmol) 8 [19], 4 Å activated molecular sieves (0.5 g), (R)-(+)-2-
methyl-2-propanesulfinamide (0.288 g, 2.38 mmol) and a microwave magnetic stir bar. Dry 
toluene (5 mL) was inserted and the mixture was stirred during 10 min at 20 °C. Ti(OEt)4 (0.41 
g, 1.78 mmol) was added, the vial was sealed and the reaction mixture was heated at 110 °C 
for 1.5 h under microwave irradiation. After cooling to room temperature, the cap was removed 
and the brown solution was diluted (CH2Cl2, 50 mL). Brine was added (50 mL) and the mixture 
was stirred for 5 min. Molecular sieves and the precipitate were filtered over celite and the cake 
was rinsed with CH2Cl2 (3 × 20 mL). The phases were separated and the aqueous phase was 
extracted twice with CH2Cl2 (2 × 20 mL).  The combined organic layers were then dried over 
MgSO4, filtered over a cotton plug and evaporated under reduced pressure. The crude 
compound product was purified by column chromatography (SiO2, EtOAc : PE, 1:1) to provide 
(SR)-9 as yellow oil (0.48 g, 77%). Mixture of anomers ca. 8:2, not assigned. Rf 0.38 (SiO2, 
EtOAc : PE, 1:1). 1H NMR (400 MHz, CDCl3/TMS): δ 7.40–7.19 (m, 15 H, HAr), 5.64 (br s, 
0.7 H, NH maj.), 5.05 (br d, J = 7.8 Hz, 0.8 H, H-1 maj.), 4.97 (dd, J = 8.0, 5.4 Hz, 0.2 H, H-1 
min.), 4.70–4.42 (m, 6 H, OCH2Ph maj.OCH2Ph min.), 4.07 (dd, J = 12.8, 2.0 Hz, 0.8 H, H-
5b maj.), 3.94 (t, J = 3.2 Hz, 0.8 H, H-2 maj.), 3.90–3.75 (m, 1.6 H, H-2 min., H-5a min., H-5b 
min., H-3 maj.), 3.72–3.65 (m, 0.8 H, H-4 maj.), 3.63–3.50 (m, 1.2 H, H-5a maj., H-3 min., H-
4 min., NH min.), 1.18 (s, 1.8 H, tBu min.), 1.08 (s, 7.6 H, tBu maj.) ppm. 13C NMR (101 MHz, 
CDCl3/TMS): δ 138.2 (C, CAr min.), 138.0 (C, CAr maj.), 138.0 (C, CAr min.), 137.9 (C, CAr 
maj.), 137.8 (C, CAr min.), 137.6 (C, CAr maj.), 128.5 (CH, CHAr min.), 128.5–127.7 (CH, CHAr 
min., CHAr maj.), 82.9 (CH, C-1 maj.), 82.6 (CH, C-1 min.), 77.3 (CH, C-3 maj.), 76.2 (CH, 
C-3 min.), 74.8 (CH, C-4 min.), 74.7 (CH, C-4 maj.), 73.9 (CH2, OCH2Ph maj.), 73.5 (CH, C-
2 maj.), 73.4 (CH, C-2 min.), 73.0 (CH2, OCH2Ph min.), 71.7 (CH2, OCH2Ph maj.), 71.7 (CH2, 
OCH2Ph maj.), 71.5 (CH2, OCH2Ph min.), 71.5 (CH2, OCH2Ph min.), 64.0 (CH2, C-5 min.), 
58.7 (CH2, C-5 maj.), 56.1 (C, tBu maj.), 55.9 (C, tBu min.), 22.4 (CH3, tBu maj.), 22.4 (CH3, 
tBu min.) ppm. HRMS (ESI): calcd. for C30H38NO5S [M+H
+] 524.2471; found 524.2465. 
4.3.9. 2,3,4-Tri-O-benzyl-1-(SR)-N-tert-butanesulfinylamino-1-deoxy-L-lyxitol (SR)-10. 
Procedure C (P. C). A 5-mL microwave vial under argon atmosphere was charged with 
2,3,4-Tri-O-benzyl-L- lyxopyranose 8 [19] (0.1 g, 0.24 mmol), 4 Å activated molecular sieves 
(0.2 g), (R)-(+)-2-methyl-2-propanesulfinamide (58 mg, 0.48 mmol) and a microwave 
magnetic stir bar. Dry toluene (2 mL) was inserted and the mixture was stirred during 10 min 
at 20 °C. Ti(OEt)4 (82 mg, 0.36 mmol) was added, the vial was sealed and the reaction mixture 
was heated at 110 °C for 1.5 h under microwave irradiation. After cooling to room temperature, 
the cap was removed and the solvent was evaporated under reduced pressure (septum pierced 
by a needle). 
The crude 2,3,4-tri-O-benzyl-(SR)-N-tert-butanesulfinyl-α/β-L-lyxopyranosylamine (SR)-9 
was then dissolved by adding 5 mL of absolute ethanol, the mixture was flushed with argon 
and NaBH4 (36 mg, 0.95 mmol) was added. The reaction mixture was subsequently heated at 
80 °C under argon atmosphere, until no more of the sulfinyl intermediate was observed (2 h). 
Next, the suspension was allowed to cool down to room temperature and the solvent was 
evaporated. The residue was dissolved in CH2Cl2 (20 mL) and molecular sieves were 
eliminated by filtration through a cotton plug. The organic phase was washed with sat. aq. 
NH4Cl (20 mL) and the aqueous phase was extracted 3x with CH2Cl2 (3 × 10 mL). Combined 
organic layers were dried over MgSO4, filtered over a cotton plug and the solvent was 
evaporated under reduced pressure. The crude product was purified by column chromatography 
(SiO2, PE : EtOAc 1:2 to 1:3) to afford the titled compound (SR)-10 in 56% yield (ca. 71 mg). 
Rf 0.25 (SiO2, PE:EtOAc 1:2). [α]D20 −59.4 (c 1.5, CHCl3); 1H NMR (400 MHz, CDCl3/TMS): 
δ 7.39–7.23 (m, 15 H, HAr), 4.77–4.49 (m, 6 H, OCH2Ph), 3.93–3.86 (dd, J = 5.2, 3.8 Hz, 1 H, 
H-3), 3.85-3.76 (m, 2 H, H-2, H-5a), 3.75–3.63 (m, 3 H, H-4, H-5b, NH), 3.52–3.29 (m, 2 H, 
H-1), 2.45 (t, J = 6.1 Hz, 1 H, OH), 1.08 (s, 9 H, tBu) ppm. 1H NMR (400 MHz, Benzene-d6): 
δ 7.22–7.14 (m, 6 H, HAr), 7.03–6.92 (m, 9 H, HAr), 4.58–4.31 (m, 6 H, OCH2Ph), 3.94 (t, J = 
6.3 Hz, 1 H, OH), 3.87 (dd, J = 5.5, 3.8 Hz, 1 H, H-2), 3.83 (q, J = 5.0 Hz, 1 H, , H-3), 3.72–
3.62 (m, 2 H, H-5), 3.56 (q, J = 4.9 Hz, 1 H, H-4), 3.44–3.30 (m, 2 H, H-1), 0.80 (s, 9 H, tBu) 
ppm. 13C NMR (101 MHz, CDCl3/TMS) δ 138.1 (C, CAr), 138.1 (C, CAr), 137.8 (C, CAr), 
128.6–127.9 (CH, CHAr) 79.8 (CH), 79.4 (CH), 79.4 (CH), 74.2 (CH2, OCH2Ph), 72.7 (CH2, 
OCH2Ph), 72.1 (CH2, OCH2Ph), 61.2 (CH2, C-5), 55.7 (C, tBu), 45.6 (CH2, C-1), 22.6 (CH3, 
tBu) ppm. 13C NMR (101 MHz, Benzene-d6) δ 139.3 (C, CAr), 139.2 (C, CAr), 138.9 (C, CAr), 
128.7–127.8 (CH, CHAr) 80.8 (CH, C-4), 80.6 (CH, C-2), 79.4 (CH, C-3), 77.8 (CH, CHCl3), 
74.7 (CH2, OCH2Ph), 72.9 (CH2, OCH2Ph), 72.1 (CH2, OCH2Ph), 61.5 (CH2, C-5), 55.6 (C, 
tBu), 45.7 (CH2, C-1), 22.7 (CH3, tBu) ppm. IR (neat): 3392 (O−H), 3031 (C−H), 2930 (C−H), 
2876 (C−H), 1707, 1454 (C=C), 1043 (C−O), 736 (C−H), 691 (C−H) cm–1. HRMS (ESI): calcd 
for C30H40NO5S [M+H+]: 526.2627; found: 526.2632. 
Alternatively, compound (SR)-10 could be obtained from the reduction of isolated 2,3,4-
tri-O-benzyl-(SR)-N-tert-butanesulfinyl-α/β-L-lyxopyranosylamine (SR)-9. 
An oven-dried 5-mL single-necked round-bottomed flask under argon atmosphere, was 
charged with compound (SR)-9 (90 mg, 0.17 mmol), and absolute ethanol (5 mL). NaBH4 (26 
mg, 0.69 mmol) was then added, portionwise, and the reaction mixture was stirred at 80 °C for 
2 h. The suspension was allowed to cool down to room temperature and the solvent was 
removed by rotary evaporation. The crude residue was dissolved in EtOAc (20 mL) and the 
organic phase was washed with sat. brine (20 mL). Next, the aqueous layer was discarded and 
the organic phase was dried (MgSO4), filtered over a cotton plug and evaporated under reduced 
pressure. The crude product was purified by column chromatography (SiO2, PE:EtOAc 1:2 to 
1:3) to provide compound (SR)-10 in moderate yield (58 mg, 64%). 
4.3.10. 2,3,4-Tri-O-benzyl-1,5-dideoxy-1,5-imino-L-lyxitol 11. 
Compound 11 was synthesized from amino-L-lyxitol (SR)-10 according to G.P. B. It was 
isolated as a colorless syrup (18 mg, 44% over two steps) after purification by chromatography 
(SiO2, CH2Cl2:MeOH 100:1 to 30/1). Rf 0.4 (SiO2, CH2Cl2:MeOH 15:1). [α]D20 +33.0 (c 1.0, 
CHCl3); 
1H NMR (400 MHz, CDCl3/TMS): δ 7.43–7.22 (m, 15 H, HAr), 4.77–4.53 (m, 6 H, 3 
× OCH2Ph), 3.79–3.68 (m, 2 H), 3.61 (br d, J = 5.3 Hz, 1 H), 3.13 (br dd, J = 13.4, 2.8 Hz, 1 
H, H-5a or H-1a), 3.05 (dd, J = 13.6, 6.0 Hz, 1 H, H-1a or H-5a), 2.64 (br d, J = 13.8 Hz, 1 H, 
H-1b or H-5b), 2.57 (br dd, J = 13.6, 7.3 Hz, 1 H, H-5b or H-1b) ppm. 13C NMR (101 MHz, 
CDCl3/TMS): δ 138.9 (C, CAr), 138.7 (C, CAr), 138.7 (C, CAr), 128.4−127.5 (CH, CHAr), 79.8 
(CH), 76.6 (CH), 74.7 (CH), 72.5 (CH2, OCH2Ph), 72.4 (CH2, OCH2Ph), 71.4 (CH2, OCH2Ph), 
47.7 (CH2, C-5), 46.8 (CH2, C-1) ppm. IR (neat): 3310 (N−H), 3028 (C−H), 2923 (C−H), 2866 
(C−H), 1717, 1448 (C=C), 1097 (C−O), 729 (C−H), 694 (C−H) cm–1. HRMS (ESI): calcd. for 
C26H30NO3 [M+H
+] 404.2226; found: 404.2218. 
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